Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition).
10.3760/cma.j.cn441530-20221114-00467
- VernacularTitle:超全直肠系膜切除层面的原发性直肠癌和局部复发直肠癌盆腔脏器联合切除中国专家共识（2023版）
- Collective Name:China PelvEx Collaborative;Colorectal Cancer Committee of the Chinese Medical Doctor Association;Gastrointestinal Surgery Committee of China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Journal Article
- MeSH:
Humans;
Consensus;
Neoplasm Recurrence, Local/surgery*;
Pelvic Exenteration;
Quality of Life;
Rectal Neoplasms/surgery*;
Treatment Outcome;
China
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(1):16-26
- CountryChina
- Language:Chinese
-
Abstract:
Pelvic exenteration is often required for primary rectal cancer beyond total mesorectal excision (PRC-bTME) and locally recurrent rectal cancer (LRRC). Some patients with radical resection can achieve long-term survival, but they need to face risks, such as huge surgical trauma, serious perioperative complications, permanent loss of organ function and decline in quality of life. Preoperative evaluation of PRC-bTME and LRRC should emphasize multidisciplinary collaboration, and develop individualized diagnosis and treatment strategies. The principles of function preservation and risk-benefit balance in surgery oncology should be followed, and R0 resection should be emphasized. Perioperative complications, surgical trauma and organ function loss should be minimized to achieve the best quality control and balance point. This consensus was formulated by the Colorectal Cancer Committee of the Chinese Medical Doctor Association and the Gastrointestinal Surgery Committee of China International Exchange and Promotive Association for Medical and Health Care. The draft was formed based on the summary of domestic and foreign research progress and expert experience. After discussion, review and modification by experts, an anonymous voting was conducted for each major opinion, and in-depth verification was carried out according to the principles of evidence-based medicine. Finally, the Chinese expert consensus on the pelvic exenteration with primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition) was formed. This consensus mainly summarizes the indications and contraindications of PE for PRC-bTME and LRRC, preoperative diagnosis and evaluation, perioperative treatment, as well as the resection scope, surgical methods, reconstruction of related organs, safety and complications of PE, postoperative follow-up and other issues, in order to provide guidance for PE in patients with PRC-bTME and LRRC.
